Selections from The Scientist’s reading list:

  • Reviewing patterns of species decline, researchers from the University of California, Santa Barbara, and their colleagues have found evidence to suggest that the global loss of marine life is accelerating. Their results were published in Science last week (January 16). “We may be sitting on a precipice of a major extinction event,” Santa Barbara’s Douglas McCauley told The New York Times.
  • The market braces for biosimilars, as drugs that mimic biologics may soon be available to patients in the U.S. Within the next few months, the Food and Drug Administration (FDA) is set to decide whether to approve drugmaker Sandoz’s biosimilar version of Amgen’s filgrastim, which is meant for patients undergoing cancer treatment. Nature takes a look at the remaining regulatory and legal challenges.
  • A matter of perspective? People are generally “horrible at saying what the size of something...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?